scispace - formally typeset
X

Xiuping Liu

Researcher at University of Texas MD Anderson Cancer Center

Publications -  41
Citations -  7483

Xiuping Liu is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: microRNA & Regulation of gene expression. The author has an hindex of 26, co-authored 38 publications receiving 5444 citations. Previous affiliations of Xiuping Liu include Ohio State University & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally, +235 more
- 15 Jun 2017 - 
TL;DR: Integrative molecular HCC subtyping incorporating unsupervised clustering of five data platforms identified three subtypes, one of which was associated with poorer prognosis in three HCC cohorts and development of a p53 target gene expression signature correlating with poor survival was enabled.
Journal ArticleDOI

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A Hoadley, +738 more
- 05 Apr 2018 - 
TL;DR: Molecular similarities among histologically or anatomically related cancer types provide a basis for focused pan-cancer analyses, such as pan-gastrointestinal, Pan-gynecological, pan-kidney, and pan-squamous cancers, and those related by stemness features, which may inform strategies for future therapeutic development.
Journal ArticleDOI

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor, +732 more
- 09 Apr 2018 - 
TL;DR: The genomic and phenotypic correlates of cancer aneuploidy are defined and genome engineering is applied to delete 3p in lung cells, causing decreased proliferation rescued in part by chromosome 3 duplication.
Journal ArticleDOI

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.

TL;DR: The results demonstrate for the first time the roles of microRNAs in the regulation of drug resistance mediated by MDR1/P-glycoprotein, and suggest the potential for targeting miR-27a and mi-451 as a therapeutic strategy for modulating MDR in cancer cells.
Journal ArticleDOI

Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells

TL;DR: It is reported here that microRNAs (miRNAs), a class of endogenous, 22–24 nucleotide noncoding RNA molecules able to affect stability and translation of mRNA, may represent a previously unrecognized mechanism for regulating beclin 1 expression and autophagy.